Brainsway For Profit
BrainsWay Deep TMS represents the next generation of noninvasive treatment options for Depression, OCD, and Smoking Addiction. Learn about Brainsway Deep TMS treatment >>
Technology:
Biomarker panels
Headquarters:
Jerusalem, Yerushalayim, Israel
Funding Status:
N/A
Investment Stage:
N/A
Founded Date:
2003-01-01
Number Of Exists:
Post-IPO Equity
Estimated Revenue:
$1M to $10M
Employee Number:
51-100
Total Funding:
$20.3M
Industry:
Clinical Data Management
Investor Type:
Company